About this Medicine article
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction by Rossello, Xavier; Piñero, Antonio; Fernández-Jiménez, Rodrigo; Sánchez-González, Javier; Pizarro, Gonzalo; Galán-Arriola, Carlos; Lobo-Gonzalez, Manuel; Vilchez, Jean Paul; García-Prieto, Jaime; García-Ruiz, Jose Manuel; García-Álvarez, Ana; Sanz-Rosa, David; Ibanez, Borja is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rossello, Xavier; Piñero, Antonio; Fernández-Jiménez, Rodrigo; Sánchez-González, Javier; Pizarro, Gonzalo; Galán-Arriola, Carlos; Lobo-Gonzalez, Manuel; Vilchez, Jean Paul; García-Prieto, Jaime; García-Ruiz, Jose Manuel; García-Álvarez, Ana; Sanz-Rosa, David; Ibanez, Borja
- Publisher
- Springer US; Springer-Verlag; Springer New York LLC; Springer Science and Business Media LLC (ISSN 1937-5387)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)